Single and Multiple Dose Pharmacokinetics (PK) of Aramchol From an Aramchol Meglumine Tablet
Clinical trial NCT07251712 · RECRUITING
Trial details
- NCT number
- NCT07251712
- Sponsor
- Galmed Pharmaceuticals Ltd
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-25
- Primary completion
- 2026-04-15
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.